Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer.
Ma F, Guan Y, Yi Z, Chang L, Li Q, Chen S, Zhu W, Guan X, Li C, Qian H, Xia X, Yang L, Zhang J, Husain H, Liao Z, Futreal A, Huang J, Yi X, Xu B.
Ma F, et al. Among authors: li c, li q.
Int J Cancer. 2020 Mar 1;146(5):1359-1368. doi: 10.1002/ijc.32536. Epub 2019 Jul 4.
Int J Cancer. 2020.
PMID: 31241775
Clinical Trial.